查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1736710

全球醫學影像模型市場規模（按產品類型、材料、最終用戶、區域範圍和預測）

Global Medical Imaging Phantoms Market Size By Product Type (X-ray Phantoms, MRI Phantoms), By Material (Stimulating Devices, False Organs), By End-User (Hospitals, Diagnostic and Reference Laboratories), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

醫學影像模型的市場規模及預測

2024 年醫學影像模型市場規模價值為 559.7 億美元，預計到 2032 年將達到 839.6 億美元，預測期內（2026-2032 年）的複合年成長率為 5.20%。

心臟衰竭衰竭、慢性腎臟病和慢性阻塞性肺病(COPD) 等文明病導致的疾病負擔日益加重，以及對高效影像診斷程序所需的精確校準技術的需求日益成長，這些因素極大地推動了全球醫學影像模型市場的成長。本研究報告對全球醫學影像模型市場進行了全面評估，並對關鍵細分市場、趨勢、市場促進因素、競爭格局以及影響市場的關鍵因素進行了全面的分析。

推動全球醫學影像模型市場的因素

醫學影像模型市場的市場驅動力可能受到多種因素的影響，其中包括：

診斷影像需求日益成長：隨著癌症、心血管疾病、神經系統疾病等慢性疾病的發生率不斷上升，對診斷影像治療的需求也日益成長。醫學影像模型在影像系統的校準和準確性保證中發揮著至關重要的作用，這滿足了對精確診斷設備日益成長的需求。

顯像模式的技術發展：CT、MRI、超音波和核子醫學等影像技術的進步正在推動對先進體模的需求。體模可用於測試新的成像方法、改進通訊協定以及檢驗複雜成像系統的功能。

日益重視輻射安全：輻射安全在醫學影像中日益重要。體模有助於準確估算劑量，簡化成像技術，從而減少不必要的輻射暴露，對於評估和限制患者的輻射暴露至關重要。

監管要求與品質保證 醫學影像設備的品質保證必須符合歐洲藥品管理局 (EMA) 和美國食品藥物管理局(FDA) 等監管機構制定的嚴格準則。體模是遵守這些法規並確保成像系統產生可靠且統一結果的關鍵設備。

數位成像系統日益普及：醫療機構在從類比成像系統過渡到數位成像系統的過程中，需要使用模型進行驗證和校準。由於數位成像系統需要定期進行品質測試以保持影像品質和診斷準確性，因此模型的需求量很大。

全球醫療保健領域的擴張：全球醫療保健產業的擴張，尤其是在新興市場，帶動了先進醫學影像技術的使用成長。新建的醫療機構對成像模型的需求日益成長，以確保成像設備的正常運作和準確性。

醫學影像模型：廣泛用於實驗室和教育機構的培訓和研究，使研究人員和學生能夠在安全的環境中試驗和開發新的影像模式，而不會讓病患面臨不必要的風險。

人口老化：隨著世界人口老化，與老齡化相關的疾病的發生率也隨之上升，對醫學影像檢查的需求也隨之增加。模體對於維持用於識別和追蹤這些情況的成像系統的準確性和可靠性至關重要。

客製化患者專用模型：3D 列印和材料科學的發展使得創建客製化患者專用模型成為可能，旨在模擬特定的解剖特徵和疾病，從而可以對成像系統進行更準確和個性化的測試。

夥伴關係與協作：研究中心、影像設備製造商和醫療保健提供者的創新努力，為新型增強型體模的開發提供了支持。這些協作對於影像技術的發展和體模性能的提升至關重要。

限制全球醫學影像模型市場的因素

醫學影像模型市場面臨諸多限制和挑戰，其中包括：

昂貴的體模成本：醫學影像體模所使用的材料及其製造所需的精度水準使得其價格昂貴。小型醫療機構、研究機構和教育機構無力購買和使用如此昂貴的體模。

普及度和認知度有限：使用醫學影像模型的益處和意義尚不為人所知，尤其是在開發中國家。因此，醫療保健提供者可能不會優先購買用於影像校準和檢驗的模型，這可能導致其採用率較低。

技術複雜性與維護：為了獲得準確、實用的結果，使用體模需要高階技術力。此外，維護和校準體模可能既困難又耗時，這給技術人員和資源有限的設施帶來了問題。

法規與合規難題：儘管法規鼓勵使用體模，但這些法規的協商可能既困難又耗時。醫學成像體模的製造商和使用者可能難以確保符合不同地區的各種監管標準。

使用壽命有限且需要更換：隨著時間的推移，醫學影像模型會因材料劣化和磨損而失去效用，需要定期更換，從而增加總體費用並給醫療機構和研究機構帶來財務負擔。

替代技術：電腦模擬和其他數位工具是可用於校準和檢驗成像系統的替代技術和方法的範例。如果消費者在某些情況下選擇這些替代方案而非實體體模，這可能會減少對傳統體模產品的需求。

資金限制：醫療產業的資金限制和景氣衰退可能會影響對醫學影像模型及其他創新技術的投資。資金限制和預算短缺可能會迫使醫療機構優先考慮其他事項，而不是購買和維護模式。

缺乏標準化：缺乏針對醫學影像體模創建和應用的全球性指南，可能導致性能和品質參差不齊。標準化的缺乏使得跨多個研究和中心的數據難以比較，阻礙了體模的普遍應用。

在某些領域，先進成像技術的採用進展緩慢。在先進影像技術採用緩慢的地區，對匹配體模的需求也較低。這可能是由於教育、基礎設施、經濟等方面的障礙阻礙了先進影像技術的廣泛應用。

環境和材料限制：醫學影像體模的生產可能受到供應鏈和環境限制的影響，這取決於材料。這些材料的成本、可用性及其對環境的影響都會影響體模的生產和成本。

目錄

第1章 全球醫學影像模型市場介紹

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章 醫學影像模型的全球市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章全球醫學影像模型市場（依產品類型）

  • 概述
  • X光模型
  • MRI體模
  • 核醫學影像模型
  • 超音波體模
  • CT體模
  • 其他

6. 全球醫學影像模型市場（按材料）

  • 概述
  • 刺激器
  • 假器官

第7章全球醫學影像模型市場（按最終用戶）

  • 概述
  • 醫院
  • 診斷與參考實驗室
  • 學術和研究機構
  • 醫療設備製造商
  • 其他

8. 全球醫學影像模型市場：區域分析

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他
    • 拉丁美洲
    • 中東和非洲

第9章醫學影像模型市場的全球競爭格局

  • 概述
  • 各公司市場排名
  • 重點發展策略

第10章 公司簡介

  • Biodex Medical Systems, Inc.
  • Gold Standard Phantoms
  • PTW Freiburg GmbH
  • Carville Limited.
  • Computerized Imaging Reference Systems, Inc.
  • Pure Imaging Phantoms
  • Dielectric Corporation
  • Kyoto Kagaku Co., Ltd.
  • Modus Medical Devices Inc.
  • PhantomX

第11章 重大進展

  • 產品發布/開發
  • 合併與收購
  • 業務擴展
  • 夥伴關係與合作

第12章 附錄

    • 相關報告
簡介目錄
Product Code: 40239

Medical Imaging Phantoms Market Size And Forecast

Medical Imaging Phantoms Market size was valued at USD 55.97 Billion in 2024 and is projected to reach USD 83.96 Billion By 2032, growing at a CAGR of 5.20% during the forecast period 2026 to 2032.

The rising disease burden of lifestyle-related disorders such as cardiac failure, chronic kidney disease, and Chronic Obstructive Pulmonary Disease (COPD) and the increasing demand for accurate calibration techniques for effective diagnostic imaging procedures are driving the growth of the Global Medical Imaging Phantoms market significantly. The Global Medical Imaging Phantoms Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Medical Imaging Phantoms Market Drivers

The market drivers for the Medical Imaging Phantoms Market can be influenced by various factors. These may include:

Growing Need for Diagnostic Imaging: The need for diagnostic imaging treatments is being driven by the increased prevalence of chronic diseases like cancer, cardiovascular disease, and neurological disorders. Medical imaging phantoms play a crucial role in the calibration and accuracy assurance of imaging systems, which in turn supports the increasing demand for accurate diagnostic instruments.

Technological Developments in Imaging Modalities: As imaging technologies such as CT, MRI, ultrasound, and nuclear medicine continue to progress, there is an increasing demand for sophisticated phantoms. Phantoms are needed in order to test novel imaging methods, improve protocols, and verify the functionality of complex imaging systems as a result of these improvements.

Growing Concern for Radiation Safety: In medical imaging, radiation safety is becoming more and more important. By facilitating precise dose estimations and streamlining imaging techniques to cut down on needless exposure, phantoms are essential for evaluating and limiting radiation exposure to patients.

Regulatory Requirements and Quality Assurance: Medical imaging equipment quality assurance must meet strict guidelines set by regulatory organisations like the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA). Phantoms are vital instruments for adhering to these rules, guaranteeing that imaging systems generate dependable and uniform outcomes.

Growing Adoption of Digital Imaging Systems: In healthcare institutions, the transition from analogue to digital imaging systems requires the usage of phantoms for validation and calibration. Phantoms are in high demand because digital imaging systems need to undergo routine quality tests to preserve image quality and diagnostic accuracy.

Global Healthcare Sector Expansion: The use of advanced medical imaging technologies is rising as a result of the global healthcare sector's expansion, especially in emerging markets. The need for imaging phantoms to guarantee the correct operation and precision of imaging equipment in recently constructed healthcare facilities is increased by this expansion.

Medical imaging phantoms: are extensively utilised for training and research reasons in research labs and educational establishments. They give researchers and students a secure setting in which to experiment and create novel imaging methods without putting patients at needless danger.

Ageing Population: As the world's population ages, the prevalence of age-related illnesses is rising, which in turn raises demand for medical imaging tests. Phantoms are essential to maintaining the precision and dependability of imaging systems that are used to identify and track these circumstances.

Customised and Patient-Specific Phantoms: The creation of customised and patient-specific phantoms has been made possible by developments in 3D printing and materials science. With the use of these phantoms, imaging systems may be tested more precisely and individually because they are designed to mimic particular anatomical features and diseases.

Partnerships and Collaborations: The development of new and enhanced phantoms is being aided by the innovative work of research centres, imaging equipment manufacturers, and healthcare providers. These collaborations are critical to the development of imaging technology and the improvement of phantom capabilities.

Global Medical Imaging Phantoms Market Restraints

Several factors can act as restraints or challenges for the Medical Imaging Phantoms Market. These may include:

Expensive Cost of Phantoms: The materials used and the level of accuracy needed during production make medical imaging phantoms costly. Smaller healthcare facilities, research institutes, and educational organisations may find it difficult to purchase and make substantial use of these phantoms because to their high cost.

Limited Adoption and Awareness: The advantages and significance of employing medical imaging phantoms are not well known in some areas, particularly in developing nations. Healthcare providers might not prioritise purchasing phantoms for imaging calibration and validation as a result, which could result in lower adoption rates.

Technical Complexity and Maintenance: In order to achieve precise and useful results, using phantoms may require a high level of technical competence. Furthermore, these phantoms can be difficult and time-consuming to maintain and calibrate, which presents problems for institutions with little technical staff or funding.

Regulatory and Compliance Difficulties: Although phantom use is encouraged by rules, negotiating these regulations can be difficult and time-consuming. Manufacturing companies and users of medical imaging phantoms may find it difficult to ensure compliance with various regulatory standards in various geographical areas.

Limited Lifespan and Replacement Needs: Over time, material degradation or wear and tear can cause medical imaging phantoms to lose their usefulness. Regular replacement may be necessary, raising overall expenses and placing a financial strain on medical facilities and research institutes.

Alternative Techniques and Technologies: Computer simulations and other digital tools are examples of alternative techniques and technologies that can be used for imaging system calibration and validation. The demand for conventional phantom products may decline if consumers choose these substitutes for tangible phantoms in certain situations.

Financial Restraints: Investments in medical imaging phantoms and other innovative technologies may be impacted by financial restraints and downturns in the healthcare industry. Financial strains and budget shortages may force medical facilities to put other priorities ahead of buying and maintaining phantoms.

Lack of Standardisation: Variability in performance and quality might result from the absence of global guidelines for the creation and application of medical imaging phantoms. This lack of standardisation can make it difficult to compare data across many studies and institutions and impede the general adoption of phantoms.

Advanced Imaging Technologies Are Adopted Slowly in Certain Areas: There is also less of a need for matching phantoms in areas where the uptake of cutting-edge imaging technologies is sluggish. This may be the result of obstacles relating to education, infrastructure, or the economy that keep advanced imaging modalities from being widely used.

Environmental and Material Constraints: Certain materials may be subject to supply chain or environmental restrictions during the manufacturing of medical imaging phantoms. The cost, availability, and environmental effects of these materials can all have an impact on phantom manufacturing and cost.

Global Medical Imaging Phantoms Market Segmentation Analysis

The Global Medical Imaging Phantoms Market is Segmented on the basis of Product Type, Material, End-User, And Geography.

Medical Imaging Phantoms Market, By Product Type

  • X-ray Phantoms
  • MRI Phantoms
  • Nuclear Imaging Phantoms
  • Ultrasound Phantoms
  • CT Phantoms

Based on Product Type, The market is segmented into X-ray Phantoms, MRI Phantoms, Nuclear Imaging Phantoms, Ultrasound Phantoms, CT Phantoms, and Others. The X-ray phantoms segment accounts for the highest revenue share of the Global Medical Imaging Phantoms Market in 2020 and is expected to dominate the market over the forecast period owing to their wide applications in medical imaging procedures, including radiography, mammography, and angiography. The increasing adoption of new X-ray machines and imaging device applications and initiatives taken by the government and non-profit organizations to create awareness of the available imaging techniques are expected to drive demand for X-ray phantoms over the forecast period.

Medical Imaging Phantoms Market, By Material

  • Stimulating Devices
  • False Organs

Based on Material, The market is segmented into Stimulating Devices, False Organs. The stimulating devices segment is expected to hold the largest revenue share of the Global Medical Imaging Phantoms Market during the forecast period owing to the increasing usage and growing adoption of the stimulating devices for brain, lung, and cancer diagnoses have further driven the market growth of this segment.

Global Medical Imaging Phantoms Market, By End-User

  • Hospitals
  • Diagnostic and Reference Laboratories
  • Academic and Research Institutes
  • Medical Device Companies

Based on End -User, The market is bifurcated into Hospitals, Diagnostic and Reference Laboratories, Academic and Research Institutes, Medical Device Companies and Others. The hospitals segment is expected to grow at the highest CAGR during the forecast period owing to the increasing number of patients suffering from various chronic disorders along with lifestyle diseases, and raising public awareness about these disorders. Additionally, well-established healthcare infrastructure, availability of various diagnostics and treatment facilities, higher purchasing power, and the presence of highly skilled healthcare professionals are driving the growth of the Market in the hospital's segment.

Medical Imaging Phantoms Market, By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • Latin America
  • On the basis of Geography, The Global Medical Imaging Phantoms Market is classified into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. Among the regional markets, North America accounts for the largest revenue share in Global Medical Imaging Phantoms Market in 2020 and is expected to retain its dominance throughout the forecast period. The revenue growth in the North American market is mainly attributed to the increased investment in R&D activities for the development of technologically advanced medical devices for the diagnosis of various chronic disorders along with lifestyle diseases.
  • Additionally, the increasing geriatric population, rising incidence and prevalence of various chronic disorders, rising healthcare sectors, presence of skilled professionals, and wide availability of technologically advanced Medical Imaging Phantoms are the major factors that boost in the region. The market in the Asia Pacific is projected to witness expansion at a significant growth rate during the forecast period, owing to the increasing focus on the development of healthcare infrastructure and the rising prevalence of various chronic disorders such as COPD and Chronic Kidney Disease (CKD) along with lifestyle diseases in the developing nations such as China, and India in this region.

Key Players

The "Global Medical Imaging Phantoms Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Biodex Medical Systems, Inc., Gold Standard Phantoms, PTW Freiburg GmbH, Carville Limited., Computerized Imaging Reference Systems, Inc., Pure Imaging Phantoms, Dielectric Corporation, Kyoto Kagaku Co., Ltd., Modus Medical Devices Inc., PhantomX, among others.The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MEDICAL IMAGING PHANTOMS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL MEDICAL IMAGING PHANTOMS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL MEDICAL IMAGING PHANTOMS MARKET, BY PRODUCT TYPE

  • 5.1 Overview
  • 5.2 X-ray Phantoms
  • 5.3 MRI Phantoms
  • 5.4 Nuclear Imaging Phantoms
  • 5.5 Ultrasound Phantoms
  • 5.6 CT Phantoms
  • 5.7 Others

6 GLOBAL MEDICAL IMAGING PHANTOMS MARKET, BY MATERIAL

  • 6.1 Overview
  • 6.2 Stimulating Devices
  • 6.3 False Organs

7 GLOBAL MEDICAL IMAGING PHANTOMS MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Diagnostic and Reference Laboratories
  • 7.4 Academic and Research Institutes
  • 7.5 Medical Device Companies
  • 7.6 Others

8 GLOBAL MEDICAL IMAGING PHANTOMS MARKET: GEOGRAPHICAL ANALYSIS

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 The U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 The U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL MEDICAL IMAGING PHANTOMS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Biodex Medical Systems, Inc.
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Gold Standard Phantoms
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 PTW Freiburg GmbH
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Carville Limited.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Computerized Imaging Reference Systems, Inc.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Pure Imaging Phantoms
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Development
  • 10.7 Dielectric Corporation
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Kyoto Kagaku Co., Ltd.
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Modus Medical Devices Inc.
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 PhantomX
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

    • 12.1.1 Related Reports